Seong Kang - Aprogen Healthcare Non-Executive Independent Director
| 109960 Stock | KRW 487.00 11.00 2.21% |
Director
Kang Seong Hui was NonExecutive Independent Director in ENUSTECH CO., LTD since March 14, 2013. Kang currently also serves as Chief Executive Officer of another Koreabased company. Kang holds a Bachelor degree in History from Sogang University, Korea. since 2013.
| Age | 43 |
| Tenure | 11 years |
| Phone | 82 3 1782 3438 |
| Web | https://www.aprogen-hng.com |
Aprogen Healthcare Management Efficiency
Aprogen Healthcare's management efficiency ratios could be used to measure how well Aprogen Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | DIRECTOR Age | ||
| Guk Oh | UNISEM Co | 57 | |
| Hyeon Seo | SFA Engineering | 65 | |
| Yin Lee | SFA Engineering | 49 | |
| Bong Goh | SFA Engineering | 53 | |
| Gang Choi | UNISEM Co | 47 | |
| Eun Jung | UNISEM Co | 58 | |
| Sang Son | UNISEM Co | 49 | |
Management Performance
| Return On Equity | 3.02 | |||
| Return On Asset | -0.0075 |
Aprogen Healthcare Games Leadership Team
Elected by the shareholders, the Aprogen Healthcare's board of directors comprises two types of representatives: Aprogen Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aprogen. The board's role is to monitor Aprogen Healthcare's management team and ensure that shareholders' interests are well served. Aprogen Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aprogen Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Je Park, Internal Auditor | ||
| Chang Jung, Managing Director | ||
| Hui Chang, Chief Officer | ||
| Sun Park, Director | ||
| JungGwon Lee, Sr Division | ||
| Jang Park, Assistant Managing Director | ||
| ChangYong Jung, Managing Division | ||
| Wei Zhou, Director | ||
| Jae Kim, Chief Executive Officer, Director | ||
| Seong Kang, Non-Executive Independent Director | ||
| Yu Kim, Assistant Managing Director | ||
| Wei Zhao, Director | ||
| YuChan Kim, Managing Division | ||
| Jin Jung, Director | ||
| JangWoon Park, Chief Director | ||
| Xinhui Wu, Director | ||
| Hyeong Kim, Internal Auditor | ||
| Jeong Lee, Managing Director | ||
| Su Yim, Non-Executive Independent Director |
Aprogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aprogen Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.02 | |||
| Return On Asset | -0.0075 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 126 B | |||
| Shares Outstanding | 178.7 M | |||
| Shares Owned By Insiders | 59.70 % | |||
| Shares Owned By Institutions | 0.39 % | |||
| Price To Sales | 7.70 X | |||
| Revenue | 8.42 B |
Pair Trading with Aprogen Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aprogen Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aprogen Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving together with Aprogen Stock
Moving against Aprogen Stock
| 0.57 | 024110 | Industrial Bank | PairCorr |
| 0.49 | 105560 | KB Financial Group | PairCorr |
| 0.48 | 032830 | Samsung Life | PairCorr |
The ability to find closely correlated positions to Aprogen Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aprogen Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aprogen Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aprogen Healthcare Games to buy it.
The correlation of Aprogen Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aprogen Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aprogen Healthcare Games moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aprogen Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Aprogen Stock
Aprogen Healthcare financial ratios help investors to determine whether Aprogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aprogen with respect to the benefits of owning Aprogen Healthcare security.